¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Aspirin Regimen Bayer Adult Low Strength 81 mg Tablets"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® aspirin ÇÑ±Û ¾Æ½ºÇǸ°
¼³¸í   
  ½ºÅ×·ÎÀ̵尡 ¾Æ´Ñ Ç׿°Á¦ÀÇ ´ëÇ¥ÀûÀΠ¾à¹°ÀÌ´Ù. Ç׿°Áõ, ÁøÅë, ÇØ¿­ÀÇ 3°¡Áö ±â´ÉÀ» °¡Áø´Ù. ¾à¹°ÀÇ ±â´ÉÀº ÇÁ·Î½ºÅ¸±Û¶õµò(prostaglandin)ÀÇ Çü¼ºÀ» ¾ïÁ¦Çϴ °Í¿¡ ÀÇÇØ¼­ ÀÌ·ç¾îÁø´Ù. ¿°ÁõÀ̶õ ¸ö¼Ó¿¡ µé¾î¿Â À̹°ÁúÀ» Ã³¸®Çϴ °úÁ¤À¸·Î ¿©±â¿¡´Â ¿©·¯ °¡Áö ¼¼Æ÷°¡ °ü¿©ÇÑ´Ù. ÇÁ·Î½ºÅ¸±Û¶õµò´Â ¿°ÁõÀÇ °úÁ¤¿¡¼­ ¿©·¯ ¼¼Æ÷¸¦ ¸ðÀ¸´Â ±â´ÉÀ» Çϴ ¹°ÁúÀÌ´Ù. Áï ÇÁ·Î½ºÅ¸±Û¶õµòÀÇ Çü¼ºÀ» ¸·À¸¸é ¿°Áõ¿¡ °ü¿©Çϴ ¼¼Æ÷ÀÇ ÁýÇÕÀÌ ÀÌ·ç¾îÁöÁö ¾Ê¾Æ¼­ ¿°ÁõÀÌ ÀϾÁö ¾Ê´Â´Ù. ÁöÇ÷ÀÇ °úÁ¤¿¡¼­µµ ÇÁ·Î½ºÅ¸±Û¶õµòÀÌ °ü¿©ÇÑ´Ù. Ãʱ⿡ Ç÷°üÀÌ ÅÍÁ® Çǰ¡ ³¯ ¶§¿¡ À̰ÍÀ» ¸·´Â °ÍÀº Ç÷¼ÒÆÇÀÌ´Ù. Áï Ç÷¼ÒÆÇÀÌ ¸ð¿© Ç÷°üÀÇ ¼Õ»óµÈ ºÎÀ§¸¦ Æ²¾î¸·°Ô µÈ´Ù. ¿ª½Ã ÀÌ °úÁ¤¿¡¼­µµ ÇÁ·Î½ºÅ¸±Û¶õµòÀÌ Ç÷¼ÒÆÇÀ» ±× ºÎºÐ¿¡ ¸ðÀ̰ԠÇϴ ¿ªÇÒÀ» ¼öÇàÇϹǷΠ¾Æ½ºÇǸ°À» ¸ÔÀ¸¸é ÁöÇ÷ÀÌ Àß µÇÁö ¾Ê´Â´Ù. ºÎÀÛ¿ëÀ¸·Î´Â ¼ÒÈ­Àå¾Ö, ÁöÇ÷ÀÇ Àå¾Ö, ¾ÆÁÖ µå¹°Áö¸¸ ¼Ò¾Æ¿¡¼­ Ä¡¸íÀûÀΠ¶óÀÌÁõÈıºÀÌ »ý±æ ¼ö°¡ ÀÖÀ¸¹Ç·Î ¼Ò¾Æ¿¡¼± Á¶½ÉÇØ¼­ »ç¿ëÀ» ÇؾߠÇÑ´Ù. ¾Æ¼¼»ì¸®½Ç»ê ÂüÁ¶.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aspirin
    ¾Æ½ºÇǸ°
  • multifraction regimen
    ´ÙºÐÇÒ¿ä¹ý
  • regimen
    ¿ä¹ý
  • stir up regimen
    Á¶±â°Ý·Á¿ä¹ý
  • adult disease
    ¼ºÀκ´
  • adult dosage
    ¼ºÀο뷮
  • adult respiratory distress syndrome
    ¼ºÀÎÈ£Èí°ï¶õÁõÈıº
  • adult stage
    ¼ºÃæ±â
  • adult T-cell leukemia/lymphoma
    ¼ºÀÎT¼¼Æ÷¹éÇ÷º´/¸²ÇÁÁ¾
  • adult-onset obesity
    ¼ºÀιߺ´ºñ¸¸
  • bending strength
    ±ÁÈû¼¼±â, ±¼°î°­µµ
  • bonding strength
    °áÇÕ°­µµ
  • dynamic strength
    1. µ¿Àû±Ù·Â 2. µ¿Àû°­µµ
  • ego strength
    ÀÚ¾ÆÈû
  • ionic strength
    À̿°­µµ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aspirin
    ¾Æ½ºÇǸ°
  • adult disease
    (¢¡life style disease) »ýȰ½À°üº´
  • strength
    Èû, ¼¼±â
  • bending strength
    ±ÁÈû¼¼±â, ±¼°î°­µµ
  • physical strength
    ü·Â
  • shearing strength
    ¾ù°¥¸²¼¼±â, Àü´Ü°­µµ
  • low fever
    ¹Ì¿­
  • low risk group
    ÀúÀ§Ç豺
  • low density lipoprotein
    Àú¹ÐµµÁöÁú´Ü¹é
  • very low density lipoprotein
    ÃÊÀú¹ÐµµÁöÁú´Ü¹é
  • low potency
    ÀúÈ¿´É, Àú¿ª°¡, ÀúÀáÀç·Â
  • low signal
    ¾àÇѽÅÈ£, Àú½ÅÈ£
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aspirin
    ¾Æ½ºÇǸ°
  • low-ionic-strength salt solution
    ÀúÀ̿°­µµ¿°¿ë¾×
  • mutifraction regimen
    ´ÙºÐÇÒ¿ä¹ý
  • regimen
    ¿ä¹ý
  • stir up regimen
    Á¶±â°Ý·Á¿ä¹ý
  • adult disease
    ¼ºÀκ´
  • adult dosage
    ¼ºÀο뷮
  • adult hemoglobin
    ¼ºÀÎÇ÷»ö¼Ò
  • adult stage
    ¼ºÃæ±â
  • adult ego state
    ¼ºÀÎÀھƻóÅÂ
  • low echo area
    ³·Àº¸Þ¾Æ¸®¿µ¿ª, Àú¿¡ÄÚ¿µ¿ª
  • low vision aid
    Àú½Ã·Âº¸Á¶±â
  • back strength
    µîÈû
  • bending strength
    ±ÁÈû¼¼±â, ±¼°î°­µµ
  • bonding strength
    °áÇÕÈû
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fractionation regimen
    ¼±·®ºÐÇÒ°ø½Ä
  • fracture strength
    ÆÄÀý °­µµ.
  • fracture strength
    ÆÄÀý°­µµ.
  • fringe magnetic field strength
    ÁÖº¯ ÀÚÀå ¼¼±â
  • physical strength
    ü·Â(ô÷æ³).
  • Castellani-Low symptom
    Ä«½ºÅÚ¶ó´Ï-·Î¿ìÁõ»ó.
  • LDL = low density lipoprotein
    Àú¹ÐµµÁö´Ü¹é(î¸ÚËÓøò·Ó±ÛÜ)
  • VLDL => very low density lipoprotein
    ÃÊÀú¹ÐµµÁö ´Ü¹éÁú
  • frequency deafness, low
    ÀúÁ֯ijó, ÀúÁÖÆÄ±Í¸ÔÀ½
  • hellp(hemolysis, elevated liver enzymes, low platelet),heliminths
    À±Ãæ(ëÌõù)
  • Hb A hemoglobin adult
    ¼ºÀÎÇü Çì¸ð±Û·Îºó
  • WAIS= Wechsler Adult Intelligence Scale
    ¿þÅ©½½·¯¼ºÀÎÁö´É°Ë»ç(~à÷ìÑò±ÒöËþÞÛ).
  • adult T Cell leukemia virus
    ¼ºÀÎ T ¼¼Æ÷ ¹éÇ÷º´ ¹ÙÀÌ·¯½º
  • adult T cell leukemia virus (HTLV)
    ¼ºÀÎT¼¼Æ÷ ¹éÇ÷º´ ¹ÙÀÌ·¯½º
  • adult adrenogenital syndrome
    ¼ºÀÎ ºÎ½Å ¼º±â ÁõÈıº
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • low-ionic--strength salt solution =LISS
    ÀúÀ̿°­µµ¿°¿ë¾×
  • low-ionic-strength salt solution TEST = LISS test
    ÀúÀ̿°­µµ¿°¿ë¾×
  • aspirin
    ¾Æ½ºÇǸ°.
  • aspirin
    ¾Æ½ºÇǸ°
  • aspirin
    ¾Æ½ºÇǸ°
  • fractionation regimen
    ¼±·®ºÐÇÒ°ø½Ä
  • mutifraction regimen
    ´ÙºÐÇÒ¿ä¹ý
  • stir up regimen
    Á¶±â°Ý·Á¿ä¹ý(ðÄѢ̭åú èþÛö).
  • adult T Cell leukemia virus
    ¼ºÀÎ T ¼¼Æ÷ ¹éÇ÷º´ ¹ÙÀÌ·¯½º
  • adult T cell leukemia virus (HTLV)
    ¼ºÀÎT¼¼Æ÷ ¹éÇ÷º´ ¹ÙÀÌ·¯½º
  • adult adrenogenital syndrome
    ¼ºÀÎ ºÎ½Å ¼º±â ÁõÈıº
  • adult disease
    ¼ºÀκ´(à÷ìÑÜ»).
  • adult dosage
    ¼ºÀη®(¡­åÖ).
  • adult dosage =a. dose
    ¼ºÀη®, ¼ºÀο뷮.
  • adult education
    ¼ºÀα³À°(ÊÙË´Ëô).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aspirin
    ¾Æ½ºÇǸ°
  • adult hemoglogin
    ¼ºÀÎ(à÷ìÑ) Çì¸ð±Û·Îºó
  • adult rickets
    ¼ºÀÎ ±¸·çº´ (à÷ìÑϣץܻ)
  • adult-onset diabetes
    ¼ºÀÎ ´ç´¢º´(à÷ìÑ ÓØÒãÜ»)
  • bond strength
    °áÇÕ·Â(Ì¿ùêÕô)
  • dipole strength
    ½Ö±ØÀÚ(äªÐ¿í­) ¼¼±â
  • eluent strength
    ¿ë¸®(éÁ×î) ¼¼±â
  • ionic strength
    À̿ °­µµ(Ë­Óø)
  • promoter strength
    ÇÁ·Î¸ðÅÍ °­µµ(Ë­Óø)
  • rotational strength
    ȸÀü(üÞï®) ¼¼±â
  • low-angle x-ray diffraction
    ¼Ò°¢(á³ÊÇ) X-¼±È¸Àý(àÊüÞï¹)
  • low background counter
    ³·Àº¹ÙÅÁ °è¼ö±â(ͪâ¦Ðï)
  • low-copy number
    Àú(î¸)Ä«ÇǼö(â¦)
  • low-density fraction
    Àú¹ÐµµºÐȹ(î¸ÚËÓøÝÂüñ)
  • low-density lipoprotein
    Àú¹Ðµµ Áö´Ü¹éÁú(î¸ÚËÓøò·Ó±ÛÜòõ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • adult
    ¼ºÀÎ
  • aspirin
    ¾Æ½ºÇǸ°
  • regimen
    ¼·»ý, ¾ç»ý¹ý
  • field strength
    ÀÚÀå¼¼±â, ÀÚÀå·Â
  • fringe magnetic field strength
    ÁÖº¯ÀÚÀå¼¼±â
  • magnetic field strength
    ÀÚÀå¼¼±â, ÀڱⰭµµ
  • maximum gradient strength
    ÃÖ´ë°æ»ç°­µµ
  • peak gradient strength
    ÃÖ°í°æ»ç¼¼±â
  • fast Low Angle Shot [=FLASH]
    °í¼ÓÀú°¢¿µ»óȹµæ
  • low attenuation
    ³·Àº °¨¾à
  • low back pain
    ¿äÅë
  • low echo area
    Àú¿¡ÄÚ±¸¿ª
  • low field MR scanner
    ÀúÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
  • low intensity void in proton flow
    ¾ç¼ºÀÚÈ帧ÀÇ Àú°­µµ¼Ò½Ç
  • low pass filter
    ÀúÅë°ú¿©°ú±â
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
DS dead air space; dead space; deep sedative; deep sleep; defined substrate; dehydroepiandrosterone sul...
ASA acetylsalicylic acid; active systemic anaphylaxis; Adams-Stokes attack; American Society of Anesthes...
LP labile peptide; labile protein; laboratory procedure; lactic peroxidase; lamina propria; laryngophar...
LIS laboratory information system; lateral intercellular space; left intercostal space; library informat...
Tabs tablets
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
RRT Regimen related toxicity
I regimen
LISS Low ionic strength solutions
ASA Aspirin
AIA Aspirin induced Asthma
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • aspirin
    ¾Æ½ºÇǸ°
    Ç׿°Áõ, ÁøÅë ¹× ÇØ¿­Á¦. PGs »ýÇÕ¼º °úÁ¤¿¡¼­ syclooxygenase¸¦ ¾ïÁ¦ÇÏ¿© ¿°Áõ ¹ÝÀÀ¿¡¼­ ¾ß±âµÇ´Â ¿©·¯ °¡Áö ÀÓ»ó Áõ»óÀ» ¼Ò½ÇÄÉ ÇÑ´Ù. ¶ÇÇÑ Ç÷¼ÒÆÇ ÀÀÁýÀ» ¾ïÁ¦ÇÏ´Â ÀÛ¿ëÀÌ ÀÖÀ¸¸ç ºÎÀÛ¿ëÀ¸·Î´Â ¼ÒÈ­¼º ±Ë¾çÀ» ÀÏÀ¸Å³ ¼ö ÀÖ´Ù.
  • regimen
    ¼·»ý¹ý, ¾ç»ý¹ý, Ä¡·á¹ý
    ¸ñÇ¥ ´Þ¼ºÀ» À§ÇÏ¿© ¸¸µé¾îÁø ½Ä»ç, ¿îµ¿ ±âŸÀÇ »ýȰ»óÀÇ ¾ö¹ÐÇÑ ±ÔÁ¦.
  • low biscuit stage µµÀç ÀÔÀÚ°¡ ¼­·Î ÀÀÁýµÇ³ª ´Ù°ø¼ºÀ̸ç, ºÎ¼­Áö±â ½¬¿î »óÅÂ.

    low blood pressure

    ÀúÇ÷¾Ð
    Ç÷¾Ð°è·Î Àü¿Ï µ¿¸ÆÀÇ Ç÷¾ÐÀ» ÃøÁ¤ÇÏ¿´À» ¶§ Ç÷¾ÐÀÌ Á¤»óº¸´Ù ³·Àº °æ¿ìÀÇ ÃÑĪ. Á¤»ó °ªÀº ¿¬·É, ¼º¿¡ µû¶ó ´Ù¸£Áö¸¸, ´ë°³ ÃÖ°í Ç÷¾ÐÀÌ 100 mmHg ÀÌÇÏÀ̸é ÀúÇ÷¾ÐÀ̶ó°í ÇÑ´Ù. ±×·¯³ª °íÇ÷¾ÐÁõÀÇ »ç¶÷ÀÌ ±Þ°ÝÈ÷ Ç÷¾ÐÀÌ ¶³¾îÁø °æ¿ì´Â Ç÷¾ÐÄ¡°¡ ºñ·Ï Á¤»ó ¹üÀ§¶ó ÇÒÁö¶óµµ ÀúÇ÷¾Ð Áõ¼¼¸¦ ÃÊ·¡ÇÏ´Â ¼ö°¡ ÀÖ´Ù. ÀúÇ÷¾ÐÀ» ÃÊ·¡ÇÏ´Â ÁúȯÀ¸·Î¼­´Â Å©°Ô ¸¸¼º Áö¼Ó¼º ÀúÇ÷¾ÐÁõ°ú ±â¸³¼º ÀúÇ÷¾Ð ¹× ¼îÅ©°¡ ÀÖ´Ù.¡¼¸¸¼º Áö¼Ó¼º ÀúÇ÷¾ÐÁõ¡½ °¢Á¾ÀÇ ½É Áúȯ
  • low-voltage low-amperage biphasic current
    ÀúÀü¾Ð ÀúÀü·ùÀÇ º¹Çü Àü·ù
  • low-voltage, low-amperage, biphasic current
    ÀúÀü¾Ð ÀúÀü·ùÀÇ º¹Çü Àü·ù
  • adult
    ¼ºÀÎ
    ¿ÏÀüÈ÷ ¼ºÀåÇÏ¿´°Å³ª ¼º¼÷µÈ »ý¹°Ã¼.
  • adult celiac disease
    ¼ºÀÎÇü ¼¿¸®¾ÆÅ©
    Áö¹æº¯ÁõÀÇ ¼ºÀκ´ ¶Ç´Â ºñ¿­´ë¼º ½ºÇÁ·ç¿ì.
  • adult dosage
    ¼ºÀη®
  • adult education
    ¼ºÀÎ ±³À°
    ¿ì¸® ³ª¶ó¿¡¼­´Â »çȸ ±³À°°ú °ÅÀÇ °°Àº ¶æÀ¸·Î »ç¿ëµÇ¸ç, Çб³ ±³À°À» ¼ö·áÇÑ ¼ºÀο¡ ´ëÇÑ ±³À° Ȱµ¿ ¸ðµÎ¸¦ °¡¸®Å²´Ù. º»·¡´Â ¼öÇÐÀÚÀÇ ÀÚ¹ßÀûÀÎ ÀÇÁö³ª ÀÚ±â Ȱµ¿¿¡ ÀǰÅÇÑ ±³À° ¿ä±¸ÀÇ ³ô¾ÆÁüÀ» ¹è°æÀ¸·Î ÇÏ´Â Àڱ⠱³À°È°µ¿ÀÇ ¼º°ÝÀ» °¡Áö³ª, ±Ù´ë ÀÚº»Á¦ »çȸ¿¡ ¹ß»ýÇÑ ³ëµ¿ ¹®Á¦³ª »çȸ ¹®Á¦¿¡ ´ëóÇÏ´Â ±³È­ Á¤Ã¥ÀÇ Ãø¸éµµ °®´Â´Ù. ¼ö´ÜÀ¸·Î¼­´Â ¼ºÀÎ ÇбÞ, °­¿¬È¸, Åë½Å ±³À°, ´ëÇÐ È®Àå °­Á µîÀÌ ÀÖÀ¸³ª, »ý¾Ö ±³À° Áß¿¡¼­ Á¡ÇÏ´Â ºñÀ²ÀÌ ±ÝÈÄ ÇÑÃþ ³ô¾ÆÁú °ÍÀÌ´Ù.
  • adult hemoglobin
    ¼ºÀÎÇü Çì¸ð±Û·Îºó
  • adult myxedema
    ¼ºÀÎÇü Á¡¾× ¼öÁ¾
  • adult respiratory distress syndrome
    ¼ºÀμº È£Èí°ï¶õ ÁõÈıº
    ¿Ü»ó ¸çÄ¥ ÈÄ¿¡ ¹ß»ýÇÏ´Â °©ÀÛ½º·¯¿î Æó °£Áú ¹× ÆóÆ÷ÀÇ ºÎÁ¾. ÀÌ´Â ³ú ¼Õ»ó ȤÀº Àú»ê¼ÒÁõ¿¡ ÀÇÇØ »ý±â´Â °ú°ÝÇÑ ±³°¨½Å°æ°è Ç×Áø ¶Ç´Â ¸ð¼¼Ç÷°ü Åõ°ú¼ºÀÇ Áõ°¡°¡ ¿øÀÎÀ¸·Î »ý°¢µÈ´Ù.
  • adult rickets
    °ñ¿¬È­Áõ
    ¸ðµç ÁöÁö°ñÀÇ ½ÉÇÑ ±âÇü°ú °ñÀý.
  • adult T cell leukemia
    ¼ºÀÎ T¼¼Æ÷ ¹éÇ÷º´
    ¹ßÁõ ¿¬·ÉÀº Æò±Õ 51¼¼, ÀϺ» Kyushu, Shikoku, Kii ¹Ýµµ Áö¹æ¿¡¼­ ´Ù¹ßÇϰí ÇǺΠħÀ± ¹× °£Àå, ºñÀå, ¸²ÇÁÀý Á¾´ë¸¦ ÈçÈ÷ º¼ ¼ö Àִµ¥ ºóÇ÷Àº ¾ø´ø°¡, À־ °æµµ, °ñ¼ö¿¡ÀÇ Ä§À±Àº º¸Åë ÇöÀúÇÏÁö ¾Ê´Ù. 50% »ýÁ¸Àº 4.4°³¿ù·Î ª´Ù. ¹éÇ÷º´ ¼¼Æ÷ÀÇ Æ¯Â¡Àº ÇÙÀÌ ÀÌÇüÀÌ¸ç ºÐ¿±»ó, È­ÆÇ»ó µîÀ¸·Î Áø´Ü¿¡ »ç¿ëµÈ´Ù.
  • adult teratoma
    ¼ºÀμº ±âÇüÁ¾, ¼º¼÷¼º ±âÇüÁ¾
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
Bayer's patches Sites of adhesion between the outer and cytoplasmic membranes of gram-negative bacteria.
(18 Nov 1997)
aluminum aspirin An analgesic and antipyretic.
Synonym: aluminum acetylsalicylate.
(05 Mar 2000)
aspirin <drug> Acetyl salicylate. An analgesic, antipyretic and antinflammatory drug. It is a potent cyclooxygenase inhibitor and blocks the formation of prostaglandins from arachidonic acid.
(18 Nov 1997)
regimen 1. Orderly government; system of order; adminisration.
2. Any regulation or remedy which is intended to produce beneficial effects by gradual operation; especially.
<medicine> A systematic course of diet, etc, pursed with a view to improving or preserving the health, or for the purpose of attaining some particular effect, as a reduction of flesh; sometimes used synonymously with hygiene.
3. A syntactical relation between words, as when one depends on another and is regulated by it in respect to case or mood; government. The word or words governed.
See: right, and cf. Regal, regime, regiment.
Origin: L. Regimen, -inis, fr. Regere to guide, to rule.
(12 Mar 1998)
preparative regimen <oncology> The chemotherapy and/or radiation given to BMT patients prior to transplant to kill diseased cells and/or make space for healthy new marrow and/or suppress the immune system so graft rejection does not occur.
(31 Dec 1997)
tablets Solid dosage forms, of varying weight, size, and shape, which may be molded or compressed, and which contain a medicinal substance in pure or diluted form.
(12 Dec 1998)
tablets, enteric-coated Tablets coated with material that delays release of the medication until after they leave the stomach.
(12 Dec 1998)
associative strength In psychology, the strength of a stimulus response linkage as measured by the frequency with which a stimulus elicits a particular response.
See: conditioning.
(05 Mar 2000)
biting strength The motive force created by the dynamic action of the muscles during the physiologic act of mastication.
Synonym: biting strength, masticatory force.
(05 Mar 2000)
compressive strength The maximum compression a material can withstand without failure.
(12 Dec 1998)
hand strength Force exerted when gripping or grasping.
(12 Dec 1998)
strength 1. The quality or state of being strong; ability to do or to bear; capacity for exertion or endurance, whether physical, intellectual, or moral; force; vigor; power; as, strength of body or of the arm; strength of mind, of memory, or of judgment. "All his [Samson's] strength in his hairs were." (Chaucer) "Thou must outlive Thy youth, thy strength, thy beauty." (Milton)
2. Power to resist force; solidity or toughness; the quality of bodies by which they endure the application of force without breaking or yielding; in this sense opposed to frangibility; as, the strength of a bone, of a beam, of a wall, a rope, and the like. "The brittle strength of bones."
3. Power of resisting attacks; impregnability. "Our castle's strength will laugh a siege to scorn."
4. That quality which tends to secure results; effective power in an institution or enactment; security; validity; legal or moral force; logical conclusiveness; as, the strength of social or legal obligations; the strength of law; the strength of public opinion; strength of evidence; strength of argument.
5. One who, or that which, is regarded as embodying or affording force, strength, or firmness; that on which confidence or reliance is based; support; security. "God is our refuge and strength." (Ps. Xlvi. 1) "What they boded would be a mischief to us, you are providing shall be one of our principal strengths." (Sprat) "Certainly there is not a greater strength against temptation." (Jer. Taylor)
6. Force as measured; amount, numbers, or power of any body, as of an army, a navy, and the like; as, what is the strength of the enemy by land, or by sea?
7. Vigor or style; force of expression; nervous diction; said of literary work. "And praise the easy vigor of a life Where Denham's strength and Waller's sweetness join." (Pope)
8. Intensity; said of light or colour. "Bright Phoebus in his strength." (Shak)
9. Intensity or degree of the distinguishing and essential element; spirit; virtue; excellence; said of liquors, solutions, etc.; as, the strength of wine or of acids.
10. A strong place; a stronghold. On, or Upon, the strength of, in reliance upon. "The allies, after a successful summer, are too apt, upon the strength of it, to neglect their preparations for the ensuing campaign." .
Synonym: Force, robustness, toughness, hardness, stoutness, brawniness, lustiness, firmness, puissance, support, spirit, validity, authority. See Force.
Origin: OE. Strengthe, AS. Strengu, fr. Strang strong. See Strong.
Source: Websters Dictionary
(01 Mar 1998)
strength-duration curve A graph relating the intensity of an electrical stimulus to the length of time it must flow to be effective.
See: chronaxie, rheobase.
(05 Mar 2000)
ionic strength Symbolised as g/2 or I and set equal to 0.5&sigma;mizi2, where mi equals the molar concentration and zi the charge of each ion present in solution; if molar concentrations (ci) are used instead of molality (and the solution is dilute), then I == 0.5(1/&rho;o)&sigma;cizi2 where &rho;o is the density of the solvent; a number of biochemically important events (e.g., protein solubility and rates of enzyme action) vary with the ionic strength of a solution.
(05 Mar 2000)
tensile strength The maximum stress a material subjected to a stretching load can withstand without tearing.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aspirin
    ¾Æ½ºÇǸ°
  • regimen
    ½ÄÀÌ¿ä¹ý; ¼·»ý(¼·»ý)
  • aspirin
    ¾Æ½ºÇǸ°
  • regimen
    (½Ä¤µ,.¿îµ¿ µî¿¡ÀÇÇÑ)¼·»ý;¾ç»ý¹ý;Áö¹è;ÅëÄ¡;°ü¸®;Áö¹è;(ÀüÄ¡»çÀÇ)ÇÇÁö¹è¾î;¸ñÀû¾î
  • adult
    ¼ºÀÎ,¼º¼÷ÇÑ
  • adult
    ¼ºÀÎ;¼ºÀÎÀÇ;¾î¸¥;¾î¸¥ÀÇ
  • adult education
    ¼ºÀα³À°
  • consenting adult
    µ¿ÀǼºÀÎ(¹ýÀ¸·Î ³²»öÀÌ Çã¿ëµÇ´Â 21¼¼ÀÌ»ó ³²ÀÚ);È£¸ð
  • strength
    Èû,¼¼·Â,ÀåÁ¡
  • field strength
    ÀåÀÇ ¼¼±â;Àü°è °­µµ
  • impact strength
    (Àç·áÀÇ)Ãæ°Ý °­µµ
  • radio field intensity (strength)
    ÀüÆÄ °­µµ;ÀüÀÚÀå °­µµ
  • strength
    Èû;°­Çϱâ;°­µµ;³óµµ;º´·Â;È¿·Â;ÀúÇ×(³»±¸)·Â;ÈûÀÌ µÇ´Â °Í;ÀÇÁö;on the ~ of;...À» ÀÇÁöÇÏ¿©(¹Ð°í)
  • low
    ³·Àº,³·°Ô,õÇϰÔ,(¼Ò°¡)¿ï´Ù
  • low-minded
    ºñ¿­ÇÑ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á